The majority of ETV6/RUNX1-positive patients had combined moderate anemia and thrombocytopenia at the onset of disease, with a significantly higher proportion than the negative group (55 vs. 49.9%, P< 0.001; 75.0 vs. 70.9%, P= 0.007, respectively). Here, ETV6 is linked to anemia.